| Date Checked | 2026-02-19 22:17:04 |
|---|---|
| Graham Number | (PB)229.37 vs (PE)117.84 |
| Over / Under Value Percentage | 151.50% vs 200.13% |
| Dividend Yield | 0.27% |
| Dividend Date | 2026-01-15 |
| Symbol | TMO |
| AssetType | Common Stock |
| Name | Thermo Fisher Scientific Inc |
| Description | Thermo Fisher Scientific Inc. (TMO) stands as a leading global provider of scientific instrumentation, reagents, consumables, and software, catering to essential sectors including healthcare, life sciences, and academic research. Headquartered in Waltham, Massachusetts, the company emerged from the merger of Thermo Electron and Fisher Scientific in 2006, propelling it to the forefront of innovation in analytical technologies and laboratory efficiencies. With a steadfast commitment to delivering customer-centric solutions and continuous investment in research and development, Thermo Fisher not only facilitates groundbreaking scientific advancements but also achieves approximately $30 billion in annual revenue, underlining its solid global footprint and market leadership. |
| CIK | 97745 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DIAGNOSTICS & RESEARCH |
| Address | 168 THIRD AVENUE, WALTHAM, MA, UNITED STATES, 02451 |
| OfficialSite | https://www.thermofisher.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 231868236000 |
| EBITDA | 10835000000 |
| PERatio | 35.84 |
| PEGRatio | 2.284 |
| BookValue | 135.79 |
| DividendPerShare | 1.68 |
| EPS | 17.22 |
| RevenuePerShareTTM | 115.4 |
| ProfitMargin | 0.15 |
| OperatingMarginTTM | 0.193 |
| ReturnOnAssetsTTM | 0.0494 |
| ReturnOnEquityTTM | 0.131 |
| RevenueTTM | 43735998000 |
| GrossProfitTTM | 18102000000 |
| DilutedEPSTTM | 17.22 |
| QuarterlyEarningsGrowthYOY | 0.005 |
| QuarterlyRevenueGrowthYOY | 0.049 |
| AnalystTargetPrice | 646.43 |
| AnalystRatingStrongBuy | 4 |
| AnalystRatingBuy | 17 |
| AnalystRatingHold | 5 |
| AnalystRatingSell | 0 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 35.84 |
| ForwardPE | 24.88 |
| PriceToSalesRatioTTM | 5.3 |
| PriceToBookRatio | 4.545 |
| EVToRevenue | 6.04 |
| EVToEBITDA | 23.44 |
| Beta | 0.91 |
| 52WeekHigh | 628.08 |
| 52WeekLow | 384.82 |
| 50DayMovingAverage | 576.88 |
| 200DayMovingAverage | 486.52 |
| SharesOutstanding | 375708000 |
| SharesFloat | 374795000 |
| PercentInsiders | 0.147 |
| PercentInstitutions | 92.929 |
| ExDividendDate | 2025-12-15 |
| dateChecked | 2026-02-19 22:17:04 |
| fresh | 1 |